3 -Methyl-5-hydroxy-5-trichloromethyl-1 H-1 -pyrazolcarboxyamide induces antinociception

Pharmacology Biochemistry and Behavior

Volumn 68, Issue 3, 2001, Pages 525-530

  De Souza, Fabiane Rosa ^a   Fighera, Michele Rechia ^a   Lima, Telmo Tibúrcio Fortes ^a   De Bastiani, Juliano ^a   Barcellos, Isadora Bitencourt ^a   Almeida, Cybele Esteves ^a   De Oliveira, Marli Redin ^a   Bonacorso, Hélio Gauze ^a   Flores, Ariane Ethur ^a   De Mello, Carlos Fernando ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Antinociception; Carrageenin induced paw edema; Formalin test; Pyrazole derived compounds; Rotarod test; Tail immersion test

Indexed keywords

3 METHYL 5 HYDROXY 5 TRICHLOROMETHYL 1H 1 PYRAZOLCARBOXYAMIDE; ANTINOCICEPTIVE AGENT; CARRAGEENAN; FORMALDEHYDE; NALOXONE; OPIATE ANTAGONIST; OPIATE RECEPTOR; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; LICKING; LOCOMOTION; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

ANALGESICS; ANALGESICS, OPIOID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; EDEMA; FORMALDEHYDE; IMMERSION; MALE; MICE; MORPHINE; MUSCULOSKELETAL EQUILIBRIUM; NALOXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; PYRAZOLES; RATS; RATS, WISTAR;

EID: 0035020676     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00453-1     Document Type: Article

References (35)

1. Adams PM, Beuchamp R, Alston C. Potentiation of apomorphine and dextro-amphetamine effects by naloxone. Life Sei 1981;26:629-34.
2. Akman H, Aksu F, Gultekin I, Ozbek H, Oral U, Doran F, Baysal F. A possible central antinociceptive effect of dipyrone in mice. Pharmacology 1996;53(2):71-8.
3. Anagnostakis Y, Krikos Y, Spyraki C. Pallidal substrate of morphine-induced locomotion. Eur Neuropsychopharmacol 1992;2:65-72.
4. Beirith A, Santos ARS, Rodrigues ALS, Creczynski-Pasa TB, Calixto JB. Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action. Eur J Pharmacol 1998;345:233-45.
5. Beleslin DB, Samardzic R, Krstic SK, Micic D. Differences in central effects of beta-endorphin and enkephalins: beta-endorphin. A potent psychomotor stimulant. Neuropharmacology 1982;21:99-102.
6. Bonacorso H, Oliveira MR, Wentz AP, Wastowsky AD, Oliveira AB, Höerner M, Zanatta N, Martins MAP. Haloacetylated enol ethers: 12 [18]. Region specific synthesis and structural determination of stable 5-hydroxy-1H-pyrazolines. Tetrahedron 1999;55:345-52.
7. Borne RF. Nonsteroidal anti-inflammatory drugs. In: Foye WO, Lemke TL, Williams DA, editors. Medicinal chemistry. Baltimore: Williams and Wilkins, 1995. pp. 535-80.
8. Carlsson KH, Jurna I. The role of descending inhibition in the antinociceptive effects of the pyrazolone derivatives, metamizole (dipyrone) and aminophenazone ('Pyramidon'). Naunyn-Schmiederberg's Arch Pharmacol 1987;335:149-54.
9. Correa CR, Calixto JB. Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse. Br J Pharmacol 1993;110:193-8.
10. Ferreira SH, Vane JR. New aspects of the mode of action nonsteroid antiinflammatory drugs. Annu Rev Pharmacol 1974;14:57-73.
11. Goel A, Madan AK. Structure-activity study on anti-inflammatory pyrazole carboxylic acid hydrazide analogs using molecular connectivity indices. J Chem Inf Comput Sei 1995;35:510-4.
12. Holzman SG. Stimulation of behavior in the rat by cyclazocine: effects of naloxone. J Pharmacol Exp Ther 1974; 187:380-90.
13. Holzman SG, Jewett RE. Behavioral effects of separate and combined administration of naloxone and D-amphetamine. J Pharmacol Exp Ther 1973;189:51-60.
14. Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987;30:103-14.
15. Hunskaar S, Berge O, Hole K. A modified hot-plate test sensitive to mild analgesics. Behav Brain Res 1986;21:101-8.
16. Insel PA. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. The pharmacological basis of therapeutics. New York: McGraw-Hill, 1996. pp. 617-57.
17. Janssen PAJ, Niemegeers CJE, Dony JGH. The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats. Arzeneimittelforschung 1963; 13:502-7.
18. Kimmel HL, Holtzman SG. Mu opioid agonists potentiate amphetamineand cocaine-induced rotational behavior. J Pharmacol Exp Ther 1997; 282:734-46.
19. Kuo S, Huang L-J, Nakamura H. Studies on heterocyclic compounds: 6. Synthesis and analgesic and anti-inflammatory activities of 3,4-dimethylpyrano[2,3-c]pyrazol-6-one derivatives. J Med Chem 1984;27: 539-44.
20. Leventhal L, Cole JL, Bodnar RJ. Reductions in locomotor activity following central opioid receptor opioid subtype antagonists in rats. Physiol Behav 1996;60:833-6.
21. Lorenzetti BB, Ferreira SH. Mode of analgesic action of dipyrone: direct antagonism of inflammatory hyperalgesia. Eur J Pharmacol 1985;114: 375-81.
22. Malmberg AB, Yaksh TL. Antinociceptive actions of nonsteroidal antiinflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992;263:136-46.
23. McCormack K, Prather P, Chapleo C. Some insights into the effects of opioids in phasic and tonic nociceptive tests. Pain 1998;78:79-98.
24. Rocha JBT, Mello CF. Handling during suckling alters rat behavior but does not reverse the deleterious effects of undernutrition on naltrexone-induced inhibition of exploratory activity. Int J Vitam Nutr Res 1994; 64:152-6.
25. Rotta FT, Mello CF, Rocha JBT, Souza DOG. Early undernutrition blocks the effect of naltrexone on rat exploratory behavior. Braz J Med Biol Res 1988;21:305-12.
26. Shibata M, Ohkubo T, Takahashi H, Inoki R. Modified formalin test: characteristic biphasic response. Pain 1989;38:347-52.
27. Swerdlow NR, Vaccarino FJ, Koob GF. Effects of naloxone on heroin-, amphetamine- and caffeine-stimulated locomotor activity in the rat. Pharmacol, Biochem Behav 1985;23:499-501.
28. Taylor J, Mellstrom B, Fernaud I, Naranjo JR. Metamizol potentiates morphine effects on visceral pain and evoked c-Fos immunoreactivity in spinal cord. Eur J Pharmacol 1998;351:39-47.
29. Toyoshi T, Ukai M, Kameyama T. Combination of a delta opioid receptor agonist with the Dl-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice. Eur J Pharmacol 1992;213:25-30.
30. Tsuda M, Suzuky T, Misawa M, Nagase H. Involvement of the opioid system in the anxiolytic effect of diazepam in mice. Eur J Pharmacol 1996;307:7-14.
31. Vaz ZR, Cechinel Filho V, Yunes RA, Calixto JB. Antinociceptive action of 2-(4-bromobenzoyl)-3-methyl-4,6-dimethoxy benzofuran, a novel xanthoxyline derivative on chemical and thermal models of antinociception in mice. J Pharmacol Exp Ther 1993;278: 304-12.
32. Verderame M. Handbook of cardiovascular and anti-inflammatory agents Boca Raton (FL): CRC Press, 1986.
33. Winter CA, Reslev EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962;III:544-7.
34. Yeomans DC, Proudfit HK. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: electrophysiological evidence. Pain 1996;68:141-50.
35. Yeomans DC, Pirec V, Proudfit HK. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: behavioral evidence. Pain 1996;68:133-40.